[Endolymphatic polychemotherapy in comprehensive treatment of pulmonary cancer after a radical surgery]

Introduction of chemopreparations in lymphatic vessels are easily tolerated by patients, permitting to enhance in 1.5-2 times their dosage and to reduce the introduction duration. Application of adjuvant endolymphatical polychemotherapy for a nonsmall cell pulmonary cancer in cases of tumor size more than 5 cm and (or) presence of metastases in regional lymphatic nodes in comparison with generally accepted polychemotherapy promotes the index of a one-year survival increase from 72 to 81.8%, three-year one-from 38 to 52.3% and five-year-from 28 to 38.6%.